688606 奥泰生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资21,834--0000
投资性房地产13,527-1.33%13,7099,33500
固定资产494,81398.96%248,698250,46698,62255,190
在建工程402,663-17.53%488,25442,29982,37411,620
无形资产109,271-1.05%110,43493,02728,11928,790
商誉0--0000
其他非流动资产85,176-8.92%93,514110,521131,05230,330
1,127,28418.09%954,610505,648340,166125,930

流动资产
货币资金977,932-25.78%1,317,5531,981,8432,179,315285,639
应收账款111,18010.22%100,870138,663208,199163,435
存货160,288-15.01%188,595193,660383,841123,726
其他流动资产1,802,65415.97%1,554,4311,875,009896,824452,379
3,052,054-3.46%3,161,4484,189,1743,668,1781,025,179

流动负债
短期借款0--0000
应付票据0--0000
应付帐款112,16644.53%77,609171,172360,65162,004
其他流动负债250,06127.22%196,554339,580353,553116,441
362,22632.12%274,163510,753714,204178,445
流动资产净值2,689,827-6.84%2,887,2853,678,4222,953,974846,734
资产总额减流动负债3,817,111-0.65%3,841,8954,184,0703,294,140972,664

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债7,980-22.80%10,33713,44320,5030
7,980-22.80%10,33713,44320,5030

总权益
    实收股本79,2810.00%79,28153,90453,90440,404
    储备项目3,725,874-0.59%3,747,9684,112,3233,219,733932,260
股东权益3,805,155-0.58%3,827,2494,166,2273,273,637972,664
非控股权益3,976-7.73%4,3094,40000